1. Home
  2. COLA vs ICAD Comparison

COLA vs ICAD Comparison

Compare COLA & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLA
  • ICAD
  • Stock Information
  • Founded
  • COLA 2024
  • ICAD 1984
  • Country
  • COLA Singapore
  • ICAD United States
  • Employees
  • COLA N/A
  • ICAD N/A
  • Industry
  • COLA
  • ICAD Medical/Dental Instruments
  • Sector
  • COLA
  • ICAD Health Care
  • Exchange
  • COLA NYSE
  • ICAD Nasdaq
  • Market Cap
  • COLA 79.8M
  • ICAD 103.3M
  • IPO Year
  • COLA 2025
  • ICAD 1986
  • Fundamental
  • Price
  • COLA $10.08
  • ICAD $3.84
  • Analyst Decision
  • COLA
  • ICAD Hold
  • Analyst Count
  • COLA 0
  • ICAD 1
  • Target Price
  • COLA N/A
  • ICAD N/A
  • AVG Volume (30 Days)
  • COLA 20.0K
  • ICAD 528.8K
  • Earning Date
  • COLA 01-01-0001
  • ICAD 05-13-2025
  • Dividend Yield
  • COLA N/A
  • ICAD N/A
  • EPS Growth
  • COLA N/A
  • ICAD N/A
  • EPS
  • COLA N/A
  • ICAD N/A
  • Revenue
  • COLA N/A
  • ICAD $19,528,000.00
  • Revenue This Year
  • COLA N/A
  • ICAD $3.65
  • Revenue Next Year
  • COLA N/A
  • ICAD N/A
  • P/E Ratio
  • COLA N/A
  • ICAD N/A
  • Revenue Growth
  • COLA N/A
  • ICAD 8.86
  • 52 Week Low
  • COLA $9.95
  • ICAD $1.18
  • 52 Week High
  • COLA $10.10
  • ICAD $4.02
  • Technical
  • Relative Strength Index (RSI)
  • COLA N/A
  • ICAD 63.85
  • Support Level
  • COLA N/A
  • ICAD $3.63
  • Resistance Level
  • COLA N/A
  • ICAD $3.85
  • Average True Range (ATR)
  • COLA 0.00
  • ICAD 0.16
  • MACD
  • COLA 0.00
  • ICAD -0.06
  • Stochastic Oscillator
  • COLA 0.00
  • ICAD 56.41

About COLA COLUMBUS ACQUISITION CORP

Columbus Acquisition Corp is a blank check company.

About ICAD iCAD Inc.

icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.

Share on Social Networks: